On the Standard Conjecture for Compactifications of Néron Models of Three-Dimensional Abelian Varieties with Multiplications in an Imaginary Quadratic Field

Mathematical Notes -     

A methodology to select suppliers to increase sustainability within supply chains

Central European Journal of Operations Research - Sustainability practice within supply chains remains in an early development phase. Enterprises still need tools that support the integration of...     

Estimation of the Sorption Activity of Silver Nanoparticles on Biodegradable Fibers of Natural and Artificial Origin

Russian Physics Journal - The specific features of the sorption activity of silver nanoparticles (AgNPs) on biodegradable polymers of natural (collagen) and artificial (polyamide 6.6) origin have...     

Formal proofs of operator identities by a single formal computation

A formal computation proving a new operator identity from known ones is, in principle, restricted by domains and codomains of linear operators involved, since not any two operators can be added or composed. Algebraically, identities can be modelled by noncommutative polynomials and such a formal computation proves that the polynomial corresponding to the new identity lies in the ideal generated by the polynomials corresponding to the known identities. In order to prove an operator identity, however, just proving membership of the polynomial in the ideal is not enough, since the ring of noncommutative polynomials ignores domains and codomains. We show that it suffices to additionally verify compatibility of this polynomial and of the generators of the ideal with the labelled quiver that encodes which polynomials can be realized as linear operators. Then, for every consistent representation of such a quiver in a linear category, there exists a computation in the category that proves the corresponding instance of the identity. Moreover, by assigning the same label to several edges of the quiver, the algebraic framework developed allows to model different versions of an operator by the same indeterminate in the noncommutative polynomials.     

Mesomorphism of Dichotomous Compounds; X-Ray Diffraction Analysis of 4-Chlorophenyl Hexadecyl Ether

Crystallography Reports - The crystal and molecular structures of Cl–C6H4–O–C16H33 (I) have been studied, and its differential scanning calorimetry (DSC) study is performed....     

Application of Synchrotron Radiation to Analyze the Friction-Induced Structural and Phase Transformations of Chrome-Nickel Austenitic Steel

Russian Physics Journal -     

Correction to: Impact of leg bending in the patient-specific computational fluid dynamics of popliteal stenting

Acta Mechanica Sinica - A Correction to this paper has been published: https://doi.org/10.1007/s10409-021-01066-2     

Versatile Near-Infrared Super-Resolution Imaging of Amyloid Fibrils with the Fluorogenic Probe CRANAD-2

CRANAD-2 is a fluorogenic curcumin derivative used for near-infrared detection and imaging in vivo of amyloid aggregates, which are involved in neurodegenerative diseases. We explore the performance of CRANAD-2 in two super-resolution imaging techniques, namely stimulated emission depletion (STED) and single-molecule localization microscopy (SMLM), with markedly different fluorophore requirements. By conveniently adapting the concentration of CRANAD-2, which transiently binds to amyloid fibrils, we show that it performs well in both techniques, achieving a resolution in the range of 45–55 nm. Correlation of SMLM with atomic force microscopy (AFM) validates the resolution of fine features in the reconstructed super-resolved image. The good performance and versatility of CRANAD-2 provides a powerful tool for near-infrared nanoscopic imaging of amyloids in vitro and in vivo.     

Effect of Plasmon Resonance of Silver Nanoparticles on the Fluorescent Properties of Doxycycline

Journal of Analytical Chemistry - Silver nanoparticles modified with Eu3+ ions increase the intensity of the fluorescence signal by a factor of 125 in an analytical system containing doxycycline as...